financetom
Business
financetom
/
Business
/
Merck discontinues development of 2 cancer drugs after trial failures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck discontinues development of 2 cancer drugs after trial failures
Dec 16, 2024 1:48 PM

Dec 16 (Reuters) - Merck ( MRK ) said on Monday it has

discontinued the development of two experimental cancer drugs

after their failure in several trials.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved